Ixico Plc (PHYOF)
0.07
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Ixico Revenue (TTM) : 9.748M for March 31, 2026
Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.748M |
| September 30, 2025 | 8.538M |
| March 31, 2025 | 8.210M |
| September 30, 2024 | 7.317M |
| March 31, 2024 | 7.540M |
| September 30, 2023 | 8.181M |
| March 31, 2023 | 9.550M |
| September 30, 2022 | 11.00M |
| March 31, 2022 | 11.21M |
| September 30, 2021 | 12.56M |
| March 31, 2021 | 12.93M |
| September 30, 2020 | 12.14M |
| March 31, 2020 | 11.04M |
| September 30, 2019 | 9.636M |
| March 31, 2019 | 7.709M |
| September 30, 2018 | 7.100M |
| March 31, 2018 | 6.214M |
| September 30, 2017 | 5.182M |
| March 31, 2017 | 4.952M |
| September 30, 2016 | 4.421M |
| March 31, 2016 | 4.593M |
| September 30, 2015 | 4.811M |
| March 31, 2015 | 4.403M |
| March 31, 2014 | 1.938M |
| Date | Value |
|---|---|
| September 30, 2013 | 0.0154M |
| March 31, 2013 | 0.002M |
| September 30, 2012 | 0.0294M |
| March 31, 2012 | 0.036M |
| September 30, 2011 | 0.1062M |
| March 31, 2011 | 0.9886M |
| September 30, 2010 | 1.068M |
| March 31, 2010 | 0.4178M |
| September 30, 2009 | 1.314M |
| March 31, 2009 | 3.460M |
| September 30, 2008 | 5.174M |
| March 31, 2008 | 4.619M |
| August 31, 2006 | 3.381M |
| February 28, 2006 | 3.451M |
| August 31, 2005 | 13.67M |
| February 28, 2005 | 11.81M |
| August 31, 2004 | 1.857M |
| February 29, 2004 | 5.051M |
| August 31, 2003 | 3.895M |
| February 28, 2003 | 3.078M |
| August 31, 2002 | 3.979M |
| February 28, 2002 | 2.692M |
| August 31, 2001 | 2.115M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (TTM) Benchmarks
| Proteome Sciences Plc | -- |
| Oxford BioDynamics Plc | 1.601M |
| ICON plc | 8.294B |
| Champions Oncology, Inc. | 59.42M |
| Silence Therapeutics Plc | 0.615M |